Global Chronic Obstructive Pulmonary Disorder Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 30544
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 92
  • list Pharmaceuticals and Healthcare

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.

The growth of the global chronic obstructive pulmonary disease (COPD) market is expected to be fueled by a high number of new, more efficacious and convenient products entering the market and commanding a greater value compared to the therapies already existing in the market. Another major factor propelling the growth of the market is the introduction of novel innovations like ultrasonic nebulizers, which are superior to the existing jet nebulizers. The competitive environment is expected to intensify with an increase in product extensions, technological innovations, and an increase in the number of mergers and acquisitions. The market for COPD drugs shows potential opportunity in both developed and developing countries. Due to the effectiveness and advancements in technology, many companies are focusing and collaborating to develop innovative COPD drugs and treatments.

In 2020, the global Chronic Obstructive Pulmonary Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Chronic Obstructive Pulmonary Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Obstructive Pulmonary Disorder development in United States, Europe and China.

The key players covered in this study

GSK

Pfizer

Merck

Novartis

AstraZeneca

Boehringer Ingelheim

Teva Pharmaceuticals

Ario Pharma

Roche

Ache

Almirall

Aquinox Pharmaceuticals

Asmacure

Astellas Pharma

Market segment by Type, the product can be split into

Short-Acting Bronchodilators

Corticosteroids

Methylxanthines

Long-Acting Bronchodilators

Phosphodiesterase-4 Inhibitors

Others

Market segment by Application, split into

Hospitals

Clinics

Others

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Chronic Obstructive Pulmonary Disorder status, future forecast, growth opportunity, key market and key players.

To present the Chronic Obstructive Pulmonary Disorder development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Chronic Obstructive Pulmonary Disorder are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type (2015-2026)

1.4.2 Short-Acting Bronchodilators

1.4.3 Corticosteroids

1.4.4 Methylxanthines

1.4.5 Long-Acting Bronchodilators

1.4.6 Phosphodiesterase-4 Inhibitors

1.4.7 Others

1.5 Market by Application

1.5.1 Global Chronic Obstructive Pulmonary Disorder Market Share by Application (2015-2026)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Chronic Obstructive Pulmonary Disorder Market Size

2.2 Chronic Obstructive Pulmonary Disorder Growth Trends by Regions

2.2.1 Chronic Obstructive Pulmonary Disorder Market Size by Regions (2015-2026)

2.2.2 Chronic Obstructive Pulmonary Disorder Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Chronic Obstructive Pulmonary Disorder Market Size by Manufacturers

3.1.1 Global Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2015-2020)

3.1.2 Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Chronic Obstructive Pulmonary Disorder Market Concentration Ratio (CR5 and HHI)

3.2 Chronic Obstructive Pulmonary Disorder Key Players Head office and Area Served

3.3 Key Players Chronic Obstructive Pulmonary Disorder Product/Solution/Service

3.4 Date of Enter into Chronic Obstructive Pulmonary Disorder Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2015-2020)

4.2 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2015-2020)

5 United States

5.1 United States Chronic Obstructive Pulmonary Disorder Market Size (2015-2020)

5.2 Chronic Obstructive Pulmonary Disorder Key Players in United States

5.3 United States Chronic Obstructive Pulmonary Disorder Market Size by Type

5.4 United States Chronic Obstructive Pulmonary Disorder Market Size by Application

6 Europe

6.1 Europe Chronic Obstructive Pulmonary Disorder Market Size (2015-2020)

6.2 Chronic Obstructive Pulmonary Disorder Key Players in Europe

6.3 Europe Chronic Obstructive Pulmonary Disorder Market Size by Type

6.4 Europe Chronic Obstructive Pulmonary Disorder Market Size by Application

7 China

7.1 China Chronic Obstructive Pulmonary Disorder Market Size (2015-2020)

7.2 Chronic Obstructive Pulmonary Disorder Key Players in China

7.3 China Chronic Obstructive Pulmonary Disorder Market Size by Type

7.4 China Chronic Obstructive Pulmonary Disorder Market Size by Application

8 Japan

8.1 Japan Chronic Obstructive Pulmonary Disorder Market Size (2015-2020)

8.2 Chronic Obstructive Pulmonary Disorder Key Players in Japan

8.3 Japan Chronic Obstructive Pulmonary Disorder Market Size by Type

8.4 Japan Chronic Obstructive Pulmonary Disorder Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (2015-2020)

9.2 Chronic Obstructive Pulmonary Disorder Key Players in Southeast Asia

9.3 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Type

9.4 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Application

10 India

10.1 India Chronic Obstructive Pulmonary Disorder Market Size (2015-2020)

10.2 Chronic Obstructive Pulmonary Disorder Key Players in India

10.3 India Chronic Obstructive Pulmonary Disorder Market Size by Type

10.4 India Chronic Obstructive Pulmonary Disorder Market Size by Application

11 Central & South America

11.1 Central & South America Chronic Obstructive Pulmonary Disorder Market Size (2015-2020)

11.2 Chronic Obstructive Pulmonary Disorder Key Players in Central & South America

11.3 Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Type

11.4 Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Application

12 International Players Profiles

12.1 GSK

12.1.1 GSK Company Details

12.1.2 Company Description and Business Overview

12.1.3 Chronic Obstructive Pulmonary Disorder Introduction

12.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.1.5 GSK Recent Development

12.2 Pfizer

12.2.1 Pfizer Company Details

12.2.2 Company Description and Business Overview

12.2.3 Chronic Obstructive Pulmonary Disorder Introduction

12.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.2.5 Pfizer Recent Development

12.3 Merck

12.3.1 Merck Company Details

12.3.2 Company Description and Business Overview

12.3.3 Chronic Obstructive Pulmonary Disorder Introduction

12.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.3.5 Merck Recent Development

12.4 Novartis

12.4.1 Novartis Company Details

12.4.2 Company Description and Business Overview

12.4.3 Chronic Obstructive Pulmonary Disorder Introduction

12.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.4.5 Novartis Recent Development

12.5 AstraZeneca

12.5.1 AstraZeneca Company Details

12.5.2 Company Description and Business Overview

12.5.3 Chronic Obstructive Pulmonary Disorder Introduction

12.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.5.5 AstraZeneca Recent Development

12.6 Boehringer Ingelheim

12.6.1 Boehringer Ingelheim Company Details

12.6.2 Company Description and Business Overview

12.6.3 Chronic Obstructive Pulmonary Disorder Introduction

12.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.6.5 Boehringer Ingelheim Recent Development

12.7 Teva Pharmaceuticals

12.7.1 Teva Pharmaceuticals Company Details

12.7.2 Company Description and Business Overview

12.7.3 Chronic Obstructive Pulmonary Disorder Introduction

12.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.7.5 Teva Pharmaceuticals Recent Development

12.8 Ario Pharma

12.8.1 Ario Pharma Company Details

12.8.2 Company Description and Business Overview

12.8.3 Chronic Obstructive Pulmonary Disorder Introduction

12.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.8.5 Ario Pharma Recent Development

12.9 Roche

12.9.1 Roche Company Details

12.9.2 Company Description and Business Overview

12.9.3 Chronic Obstructive Pulmonary Disorder Introduction

12.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.9.5 Roche Recent Development

12.10 Ache

12.10.1 Ache Company Details

12.10.2 Company Description and Business Overview

12.10.3 Chronic Obstructive Pulmonary Disorder Introduction

12.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2015-2020)

12.10.5 Ache Recent Development

12.11 Almirall

12.12 Aquinox Pharmaceuticals

12.13 Asmacure

12.14 Astellas Pharma

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Chronic Obstructive Pulmonary Disorder Key Market Segments

Table Key Players Chronic Obstructive Pulmonary Disorder Covered

Table Global Chronic Obstructi

Please fill the form below, to recieve the report sample


+1